@FierceBiotech: BU group spotlights a lethal cascade that leads to Parkinson's. FierceBiotechResearch story | Follow @FierceBiotech
@JohnCFierce: When has Pfizer ever won an R&D marathon in the last decade? | Follow @JohnCFierce
> Kite Pharma ($KITE), developing immunotherapies for cancer, signed a deal with the Netherlands' Leiden University Medical Center to collaborate on T cell receptor treatments for solid tumors related to HPV. More
> Emergent BioSolutions ($EBS) licensed Ligand Pharmaceuticals' ($LGND) R&D technology in hopes of crafting new antibody therapies. Item
> DelMar Pharmaceuticals is partnering with the University of Texas' MD Anderson Cancer Center to accelerate the development of its VAL-083 in brain cancer. News
Medical Device News
@FierceMedDev: ICYMI yesterday: Medtronic earns CE mark to use its drug-eluting balloon to help hemodialysis patients. Article | Follow @FierceMedDev
@EmilyWFierce: Zoetis slammed with up to $45M charge after EU ruling on Belgian tax scheme. FierceAnimalHealth story | Follow @EmilyWFierce
> In a win for LivaNova, the FDA approves the world's only sutureless aortic valve. Article
Pharma News
@FiercePharma: Will pharma marketing to Hispanics finally gain traction in 2016? FiercePharmaMarketing story | Follow @FiercePharma
@EricPFierce: Bayer's new plant in China will make both traditional Chinese meds and western OTC meds. FiercePharmaManufacturing report | Follow @EricPFierce
> Shire CEO thinks he can beat $500M in post-merger cost savings. More
> Depomed isn't anti-takeover, CEO says. It was just anti-Horizon. Article
Pharma Marketing News
> Will pharma marketing to Hispanics finally gain traction in 2016? More
> To flip the pricing debate, Big Pharma needs to tell some secrets. Story
> Look out, CLL. AbbVie and Roche's new venetoclax is on FDA's priority track. More
> Can Shire make the most of Baxalta's hemophilia meds? Item
> GSK's Slaoui sees 'major' vaccine market disruption for Merck as shingles candidate progresses. Article
Biotech Research News
> Cold Spring Harbor scientists develop a new drug for breast cancer. Report
> Johns Hopkins flags another possible successor to 'Special K' for depression. Story
> BU group spotlights a lethal cascade that leads to Parkinson's. More
> Slashing p75 neurotrophin receptor reduces obesity in mice: Gladstone. Article
> EPFL team creates an industrial-scale platform for stem cells. Item
Vaccines News
> Nearly a year into Novartis integration, GSK CEO won't discount vaccines spinoff. Report
> Aimmune takes peanut allergy vaccine into PhIII. More
> WHO seeks to ease cholera vaccine shortage with EuBiologics approval. Story
> Deal in Russia could cause Pfizer, GSK to lose contracts. Item
> New HIV vaccine player Aelix Therapeutics hits the scene with $12.7M Series A. Article